NIH-funded research R21 grant

How a bacterial protein affects host cell processes

Official title: DeADP-ribosylation of host targets mediated by a bacterial effector

Funded at Purdue University · NIH-10766271 · Data updated 2026-11-12

This study is looking at how the bacteria that cause Legionnaires' disease change the way our cells work by injecting special proteins, and it's for anyone interested in understanding how these infections happen and finding new ways to treat them.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionPurdue University
NIH-funded
Lab location1 site (West Lafayette, United States)
Project startJanuary 19, 2023
Project endDecember 31, 2025
Funding year2024
Award (this year)$196,250
NIH project number5R21AI171709-02
Project IDNIH-10766271 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with Legionnaires' disease or those at risk of infection from Legionella bacteria.

Less likely to help

Patients who are not affected by bacterial infections or do not have a history of Legionnaires' disease may not receive any benefit from this research.

What this research studies

This research investigates how the pathogenic bacteria Legionella pneumophila manipulates host cell functions by injecting proteins that alter cellular processes. The team uses advanced techniques to identify and analyze these proteins, focusing on their ability to modify ubiquitin, a key regulator of cellular activities. By employing activity-based probes and mass spectrometry, they aim to uncover new proteins that interact with ubiquitin and understand their roles in the bacteria's lifecycle within host cells. This work could provide insights into the mechanisms of bacterial infections and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating infections caused by Legionella pneumophila and similar pathogens.

How similar studies have gone: Previous research has shown success in understanding bacterial manipulation of host cellular processes, indicating that this approach has potential for significant findings.

Where this research is happening

  • Purdue University
    West Lafayette, United States
    Active

Researchers

  • Principal investigator: Das, Chittaranjan — Purdue University
  • Study coordinator: Das, Chittaranjan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.